PHASE 1 SARS-COV-2-Spike-Ferritin-Nanoparticle (SpFN) Vaccine With ALFQ Adjuvant for Prevention of COVID-19
Clinical trial NCT04784767 · COMPLETED
Trial details
- NCT number
- NCT04784767
- Sponsor
- U.S. Army Medical Research and Development Command
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-05
- Primary completion
- 2023-03-31
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.